T1	AdverseReaction 458 469;492 504	respiratory difficulties
T2	AdverseReaction 471 477;492 504	speech difficulties
T3	AdverseReaction 481 504	swallowing difficulties
T4	AdverseReaction 683 708	Creutzfeldt-Jakob disease
T5	AdverseReaction 710 713	CJD
T6	Negation 724 726;736 748	no transmission
T7	AdverseReaction 2347 2369	spread of toxin effect
T8	AdverseReaction 770 773	CJD
T9	AdverseReaction 1433 1446;1479 1513	toxin effects beyond the site of local injection
T11	AdverseReaction 1607 1615	asthenia
T12	AdverseReaction 1617 1644	generalized muscle weakness
T13	AdverseReaction 1646 1654	diplopia
T14	AdverseReaction 1656 1670	blurred vision
T15	AdverseReaction 1672 1678	ptosis
T16	AdverseReaction 1680 1689	dysphagia
T17	AdverseReaction 1691 1700	dysphonia
T18	AdverseReaction 1702 1712	dysarthria
T19	AdverseReaction 1714 1734	urinary incontinence
T20	AdverseReaction 1739 1761	breathing difficulties
T21	AdverseReaction 1829 1839;1854 1866	Swallowing difficulties
T22	AdverseReaction 1844 1866	breathing difficulties
T23	AdverseReaction 1922 1927	death
T24	AdverseReaction 1939 1962	spread of toxin effects
T27	AdverseReaction 2594 2604;2618 2630	swallowing difficulties
T28	AdverseReaction 2608 2630	breathing difficulties
T32	AdverseReaction 2997 3003	Deaths
T33	AdverseReaction 3032 3041	dysphagia
T34	AdverseReaction 3099 3108	Dysphagia
T35	AdverseReaction 3220 3230	Aspiration
T36	AdverseReaction 3254 3263	dysphagia
T37	AdverseReaction 3440 3459	weaken neck muscles
T38	AdverseReaction 3538 3564	loss of breathing capacity
T39	AdverseReaction 3714 3736	breathing difficulties
T40	Severity 3706 3713	serious
T41	Severity 3529 3537	critical
T42	AdverseReaction 3748 3767	respiratory failure
T46	AdverseReaction 4865 4878	eyelid ptosis
T47	AdverseReaction 5287 5296	dysphagia
T48	Severity 5280 5286	severe
T49	Severity 3025 3031	severe
T50	Severity 3247 3253	severe
T51	AdverseReaction 5301 5323	respiratory compromise
T52	AdverseReaction 5613 5627	viral diseases
T53	AdverseReaction 5668 5693	Creutzfeldt-Jakob disease
T55	AdverseReaction 5765 5779	viral diseases
T56	AdverseReaction 5783 5786	CJD
T57	Negation 5737 5739;5749 5761	No transmission
T58	Factor 658 662	risk
T29	Factor 3436 3439	may
T30	Factor 3513 3516	may
T60	Factor 5588 5592	risk
T61	Factor 5643 5647	risk
T62	AdverseReaction 752 766	viral diseases
T54	AdverseReaction 5695 5698	CJD
T10	Factor 3231 3234	may
T25	Factor 2580 2583	can
T26	Factor 1595 1598	may
T63	Factor 1447 1450	may
T59	Factor 5231 5235	risk
T31	Factor 3773 3781	Patients
T43	Factor 4738 4745	DYSPORT
E1	AdverseReaction:T1
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4 Hypothetical:E58
E5	AdverseReaction:T5
E6	Negation:T6
E7	AdverseReaction:T7
E8	AdverseReaction:T8 Negated:E6
E9	AdverseReaction:T9 Hypothetical:E63
E11	AdverseReaction:T11 Hypothetical:E26
E12	AdverseReaction:T12 Hypothetical:E26
E13	AdverseReaction:T13 Hypothetical:E26
E14	AdverseReaction:T14 Hypothetical:E26
E15	AdverseReaction:T15 Hypothetical:E26
E16	AdverseReaction:T16 Hypothetical:E26
E17	AdverseReaction:T17 Hypothetical:E26
E18	AdverseReaction:T18 Hypothetical:E26
E19	AdverseReaction:T19 Hypothetical:E26
E20	AdverseReaction:T20 Hypothetical:E26
E21	AdverseReaction:T21
E22	AdverseReaction:T22
E23	AdverseReaction:T23
E24	AdverseReaction:T24
E27	AdverseReaction:T27 Hypothetical:E25
E28	AdverseReaction:T28 Hypothetical:E25
E32	AdverseReaction:T32
E33	AdverseReaction:T33 Effect:E49
E34	AdverseReaction:T34
E35	AdverseReaction:T35 Hypothetical:E10
E36	AdverseReaction:T36 Effect:E50
E37	AdverseReaction:T37 Hypothetical:E29
E38	AdverseReaction:T38 Effect:E41 Hypothetical:E30
E39	AdverseReaction:T39 Effect:E40
E40	Severity:T40
E41	Severity:T41
E42	AdverseReaction:T42
E46	AdverseReaction:T46
E47	AdverseReaction:T47 Effect:E48 Hypothetical:E59
E48	Severity:T48
E49	Severity:T49
E50	Severity:T50
E51	AdverseReaction:T51
E52	AdverseReaction:T52 Hypothetical:E60
E53	AdverseReaction:T53 Hypothetical:E61
E55	AdverseReaction:T55 Negated:E57
E56	AdverseReaction:T56 Negated:E57
E57	Negation:T57
E58	Factor:T58
E29	Factor:T29
E30	Factor:T30
E60	Factor:T60
E61	Factor:T61
E62	AdverseReaction:T62 Negated:E6
E54	AdverseReaction:T54
E10	Factor:T10
E25	Factor:T25
E26	Factor:T26
E63	Factor:T63
E59	Factor:T59
E31	Factor:T31
E43	Factor:T43
A1	CUI E1 C0013404
A2	UMLS-Preferred-Name E1 Dyspnea
A3	MEDDRA-PT E1 Dyspnoea
A4	MEDDRA-PT-ID E1 10013968
A5	LLT E1 Difficulty breathing
A6	LLT-ID E1 10012791
A7	CUI E2 C0233715
A8	UMLS-Preferred-Name E2 Speech impairment
A9	MEDDRA-PT E2 Speech disorder
A10	MEDDRA-PT-ID E2 10041466
A11	CUI E3 C0011168
A12	UMLS-Preferred-Name E3 Deglutition Disorders
A13	MEDDRA-PT E3 Dysphagia
A14	MEDDRA-PT-ID E3 10013950
A15	LLT E3 Swallowing difficult
A16	LLT-ID E3 10042645
A17	CUI E4 C0022336
A18	UMLS-Preferred-Name E4 Creutzfeldt-Jakob disease
A19	MEDDRA-PT E4 Creutzfeldt-Jakob disease
A20	MEDDRA-PT-ID E4 10011384
A21	CUI E5 C0022336
A22	UMLS-Preferred-Name E5 Creutzfeldt-Jakob disease
A23	MEDDRA-PT E5 Creutzfeldt-Jakob disease
A24	MEDDRA-PT-ID E5 10011384
A25	LLT E5 CJD
A26	LLT-ID E5 10009217
A27	flag E7 unmapped
A28	CUI E8 C0022336
A29	UMLS-Preferred-Name E8 Creutzfeldt-Jakob disease
A30	MEDDRA-PT E8 Creutzfeldt-Jakob disease
A31	MEDDRA-PT-ID E8 10011384
A32	LLT E8 CJD
A33	LLT-ID E8 10009217
A34	flag E9 unmapped
A35	CUI E11 C0004093
A36	UMLS-Preferred-Name E11 Asthenia
A37	MEDDRA-PT E11 Asthenia
A38	MEDDRA-PT-ID E11 10003549
A39	CUI E12 C0746674
A40	UMLS-Preferred-Name E12 Generalized muscle weakness
A41	MEDDRA-PT E12 Muscular weakness
A42	MEDDRA-PT-ID E12 10028372
A43	LLT E12 Generalized muscle weakness
A44	LLT-ID E12 10062572
A45	CUI E13 C0012569
A46	UMLS-Preferred-Name E13 Diplopia
A47	MEDDRA-PT E13 Diplopia
A48	MEDDRA-PT-ID E13 10013036
A49	CUI E14 C0344232
A50	UMLS-Preferred-Name E14 Blurred vision
A51	MEDDRA-PT E14 Vision blurred
A52	MEDDRA-PT-ID E14 10047513
A53	LLT E14 Blurred vision
A54	LLT-ID E14 10005886
A55	CUI E15 C0033377
A56	UMLS-Preferred-Name E15 Ptosis
A57	MEDDRA-PT E15 Eyelid ptosis
A58	MEDDRA-PT-ID E15 10015995
A59	LLT E15 Ptosis
A60	LLT-ID E15 10037272
A61	CUI E16 C0011168
A62	UMLS-Preferred-Name E16 Deglutition Disorders
A63	MEDDRA-PT E16 Dysphagia
A64	MEDDRA-PT-ID E16 10013950
A65	CUI E17 C1527344
A66	UMLS-Preferred-Name E17 Dysphonia
A67	MEDDRA-PT E17 Dysphonia
A68	MEDDRA-PT-ID E17 10013952
A69	CUI E18 C0013362
A70	UMLS-Preferred-Name E18 Dysarthria
A71	MEDDRA-PT E18 Dysarthria
A72	MEDDRA-PT-ID E18 10013887
A73	CUI E19 C0042024
A74	UMLS-Preferred-Name E19 Urinary Incontinence
A75	MEDDRA-PT E19 Urinary incontinence
A76	MEDDRA-PT-ID E19 10046543
A77	CUI E20 C0013404
A78	UMLS-Preferred-Name E20 Dyspnea
A79	MEDDRA-PT E20 Dyspnoea
A80	MEDDRA-PT-ID E20 10013968
A81	LLT E20 Difficulty breathing
A82	LLT-ID E20 10012791
A83	CUI E21 C0011168
A84	UMLS-Preferred-Name E21 Deglutition Disorders
A85	MEDDRA-PT E21 Dysphagia
A86	MEDDRA-PT-ID E21 10013950
A87	LLT E21 Swallowing difficult
A88	LLT-ID E21 10042645
A89	CUI E22 C0013404
A90	UMLS-Preferred-Name E22 Dyspnea
A91	MEDDRA-PT E22 Dyspnoea
A92	MEDDRA-PT-ID E22 10013968
A93	LLT E22 Difficulty breathing
A94	LLT-ID E22 10012791
A95	CUI E23 C1306577
A96	UMLS-Preferred-Name E23 Death (finding)
A97	MEDDRA-PT E23 Death
A98	MEDDRA-PT-ID E23 10011906
A99	flag E24 unmapped
A100	CUI E27 C0011168
A101	UMLS-Preferred-Name E27 Deglutition Disorders
A102	MEDDRA-PT E27 Dysphagia
A103	MEDDRA-PT-ID E27 10013950
A104	LLT E27 Swallowing difficult
A105	LLT-ID E27 10042645
A106	CUI E28 C0013404
A107	UMLS-Preferred-Name E28 Dyspnea
A108	MEDDRA-PT E28 Dyspnoea
A109	MEDDRA-PT-ID E28 10013968
A110	LLT E28 Difficulty breathing
A111	LLT-ID E28 10012791
A112	CUI E32 C1306577
A113	UMLS-Preferred-Name E32 Death (finding)
A114	MEDDRA-PT E32 Death
A115	MEDDRA-PT-ID E32 10011906
A116	CUI E33 C0011168
A117	UMLS-Preferred-Name E33 Deglutition Disorders
A118	MEDDRA-PT E33 Dysphagia
A119	MEDDRA-PT-ID E33 10013950
A120	CUI E34 C0011168
A121	UMLS-Preferred-Name E34 Deglutition Disorders
A122	MEDDRA-PT E34 Dysphagia
A123	MEDDRA-PT-ID E34 10013950
A124	CUI E35 C0700198
A125	UMLS-Preferred-Name E35 Pulmonary aspiration
A126	MEDDRA-PT E35 Aspiration
A127	MEDDRA-PT-ID E35 10003504
A128	CUI E36 C0011168
A129	UMLS-Preferred-Name E36 Deglutition Disorders
A130	MEDDRA-PT E36 Dysphagia
A131	MEDDRA-PT-ID E36 10013950
A132	flag E37 underspecified
A133	CUI E37 C4022584
A134	UMLS-Preferred-Name E37 Fatigable weakness of neck muscles
A135	MEDDRA-PT E37 Muscular weakness
A136	MEDDRA-PT-ID E37 10028372
A137	LLT E37 Localised muscle weakness
A138	LLT-ID E37 10059002
A139	CUI E38 C0520829
A140	UMLS-Preferred-Name E38 Decreased total lung capacity
A141	MEDDRA-PT E38 Total lung capacity decreased
A142	MEDDRA-PT-ID E38 10044100
A143	CUI E39 C0013404
A144	UMLS-Preferred-Name E39 Dyspnea
A145	MEDDRA-PT E39 Dyspnoea
A146	MEDDRA-PT-ID E39 10013968
A147	LLT E39 Difficulty breathing
A148	LLT-ID E39 10012791
A149	CUI E42 C1145670
A150	UMLS-Preferred-Name E42 Respiratory Failure
A151	MEDDRA-PT E42 Respiratory failure
A152	MEDDRA-PT-ID E42 10038695
A153	CUI E46 C0005745
A154	UMLS-Preferred-Name E46 Blepharoptosis
A155	MEDDRA-PT E46 Eyelid ptosis
A156	MEDDRA-PT-ID E46 10015995
A157	CUI E47 C0011168
A158	UMLS-Preferred-Name E47 Deglutition Disorders
A159	MEDDRA-PT E47 Dysphagia
A160	MEDDRA-PT-ID E47 10013950
A161	CUI E51 C0035229
A162	UMLS-Preferred-Name E51 Respiratory Insufficiency
A163	MEDDRA-PT E51 Respiratory failure
A164	MEDDRA-PT-ID E51 10038695
A165	LLT E51 Respiratory insufficiency
A166	LLT-ID E51 10038701
A167	flag E52 HLGT
A168	CUI E52 C0042769
A169	UMLS-Preferred-Name E52 Virus Diseases
A170	MEDDRA-PT E52 Viral infection
A171	MEDDRA-PT-ID E52 10047461
A172	CUI E53 C0022336
A173	UMLS-Preferred-Name E53 Creutzfeldt-Jakob disease
A174	MEDDRA-PT E53 Creutzfeldt-Jakob disease
A175	MEDDRA-PT-ID E53 10011384
A176	flag E55 HLGT
A177	CUI E55 C0042769
A178	UMLS-Preferred-Name E55 Virus Diseases
A179	MEDDRA-PT E55 Viral infection
A180	MEDDRA-PT-ID E55 10047461
A181	CUI E56 C0022336
A182	UMLS-Preferred-Name E56 Creutzfeldt-Jakob disease
A183	MEDDRA-PT E56 Creutzfeldt-Jakob disease
A184	MEDDRA-PT-ID E56 10011384
A185	LLT E56 CJD
A186	LLT-ID E56 10009217
A187	flag E62 HLGT
A188	CUI E62 C0042769
A189	UMLS-Preferred-Name E62 Virus Diseases
A190	MEDDRA-PT E62 Viral infection
A191	MEDDRA-PT-ID E62 10047461
A192	CUI E54 C0022336
A193	UMLS-Preferred-Name E54 Creutzfeldt-Jakob disease
A194	MEDDRA-PT E54 Creutzfeldt-Jakob disease
A195	MEDDRA-PT-ID E54 10011384
A196	LLT E54 CJD
A197	LLT-ID E54 10009217
